Trials / Withdrawn
WithdrawnNCT02069288
Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response in Septic Shock
Effects of Fludrocortisone on Norepinephrine-mean Arterial Pressure Dose-response, Gastric Mucosal Perfusion and Arterial Stiffness in Septic Shock
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Rennes University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Septic shock (associated with relative adrenal insufficiency) is characterized by decreased arterial responsiveness to catecholamines. The association of hydrocortisone and fludrocortisone has demonstrated an improvement in survival in septic shock patients. If hydrocortisone has shown to increase vascular responsiveness, the role of fludrocortisone remains to be elucidated. The purpose of our study is to investigate the effect of a physiological dose of fludrocortisone alone on norepinephrine-mean arterial pressure dose-response relationship, gastric mucosal perfusion and arterial stiffness in patients with septic shock.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fludrocortisone | 50 µg of fludrocortisone per os |
| DRUG | Placebo | 1 tablet of placebo per os |
Timeline
- Primary completion
- 2014-02-01
- Completion
- 2014-02-01
- First posted
- 2014-02-24
- Last updated
- 2014-02-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02069288. Inclusion in this directory is not an endorsement.